• Home
  • About
    • About I-MAK
    • Our Work
    • I-Mak Directors
    • Board Of Directors
    • Advisory Board
    • Partners
    • Contact
  • Our Cases
    • Our Cases
    • FAQs
    • Lopinavir/Ritonavir
    • Abacavir Sulfate
    • Nevirapine Hemihydrate
    • Oseltamivir
    • Tenofovir
  • Testimonials
  • Media Center
    • Video/Audio
    • News Releases
    • Media Articles
    • Bios & Photos
  • Resources
    • I-MAK Blog
    • Archive
    • Publications
    • Presentations
    • Patent Landscapes
    • Pharmaceutical Patent Decisions
    • Patent Information & Databases
    • IP & Health Links
  • Donate

I-MAK

Initiative For Medicines, Access & Knowledge
  • Home
  • About
    • About I-MAK
    • Our Work
    • I-Mak Directors
    • Board Of Directors
    • Advisory Board
    • Partners
    • Contact
  • Our Cases
    • Our Cases
    • FAQs
    • Lopinavir/Ritonavir
    • Abacavir Sulfate
    • Nevirapine Hemihydrate
    • Oseltamivir
    • Tenofovir
  • Testimonials
  • Media Center
    • Video/Audio
    • News Releases
    • Media Articles
    • Bios & Photos
  • Resources
    • I-MAK Blog
    • Archive
    • Publications
    • Presentations
    • Patent Landscapes
    • Pharmaceutical Patent Decisions
    • Patent Information & Databases
    • IP & Health Links
  • Donate

  • Home
  • About
    • About I-MAK
    • Our Work
    • I-Mak Directors
    • Board Of Directors
    • Advisory Board
    • Partners
    • Contact
  • Our Cases
    • Our Cases
    • FAQs
    • Lopinavir/Ritonavir
    • Abacavir Sulfate
    • Nevirapine Hemihydrate
    • Oseltamivir
    • Tenofovir
  • Testimonials
  • Media Center
    • Video/Audio
    • News Releases
    • Media Articles
    • Bios & Photos
  • Resources
    • I-MAK Blog
    • Archive
    • Publications
    • Presentations
    • Patent Landscapes
    • Pharmaceutical Patent Decisions
    • Patent Information & Databases
    • IP & Health Links
  • Donate
Search

 

Subscribe Via RSS

 

Or Email

Enter your email address:

Delivered by FeedBurner

 

« I-MAK Works to Make Drugs Affordable for the Poor | Main | Greater Cooperation on IP Seen Under President-Elect Obama - by Liza Porteus, Kaitlin Mara and William New of IP Watch »
Sunday
Dec142008

The Women of Pop!Tech

DateSunday, December 14, 2008 at 9:52PM

Five women who participated in Pop!Tech were featured in the Fringehog blog for the work that they do, including I-MAK Director of Treatment Access, Priti Radhakrishnan.

AuthorI-Mak | Comments Off | Share ArticleShare Article
Except for publications commissioned or published by third parties all content on this site is licensed under a Creative Commons Attribution 3.0 License